Guggenheim Capital’s MediciNova MNOV Stock Holding History

Guggenheim Capital’s Portfolio MNOV Stock Details MNOV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-11,500	Closed	-$116K	–	2519
2018 Q1	$116K	Buy	+11,500	New	+$115K	﹤0.01%	2657
2017 Q4	–	Sell	-10,293	Closed	-$65K	–	2773
2017 Q3	$65K	Buy	10,293 +52	+0.5%	+$276	﹤0.01%	2682
2017 Q2	$53K	Buy	10,241 +36	+0.4%	+$202	﹤0.01%	2735
2017 Q1	$61K	Buy	10,205 +8	+0.1%	+$48	﹤0.01%	2721
2016 Q4	$61K	Buy	10,197 +28	+0.3%	+$197	﹤0.01%	2793
2016 Q3	$77K	Buy	+10,169	New	+$68.5K	﹤0.01%	2750

Other funds holding MNOV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EWM

Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Wexford Capital West Palm Beach, Florida $690M AUM 57.92% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Guggenheim Capital's MNOV Position: Q2 2018 in Review

Guggenheim Capital sold out of MediciNova (MNOV) in Q2 2018, closing a stake of 11,500 shares — an estimated $116K sold.

Guggenheim Capital first reported a position in MNOV in Q3 2016 and held it in 6 quarters. The position peaked at $116K in Q1 2018. 55 funds tracked by Wall St. Rank hold MNOV as of Q2 2018.

Guggenheim Capital reported no remaining MediciNova position as of Q2 2018 after selling out during the quarter.
Guggenheim Capital sold 11,500 MediciNova shares in Q2 2018, an estimated $116K.
Guggenheim Capital first reported a position in MediciNova in Q3 2016 and held it in 6 quarters.
Guggenheim Capital's MediciNova position peaked at $116K in Q1 2018.
55 funds tracked by Wall St. Rank held MediciNova as of Q2 2018.

Based on Guggenheim Capital's 13F filing for Q2 2018, filed 14 Aug 2018.